-
-
-
-
-
-
-
UBS Assumes Denali Therapeutics Inc. (DNLI) at Buy
-
-
-
-
-
-
-
Denali Therapeutics Inc. (DNLI) Tops Q3 EPS by 1c
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
-
-
-
-
-
-
-
Denali Therapeutics Inc. (DNLI) PT Lowered to $32 at H.C. Wainwright
-
-
-
-
-
-
-
Denali Therapeutics (DNLI) Files Mixed Shelf
-
-
-
-
-
-
-
Denali Therapeutics Inc. (DNLI) PT Lowered to $87 at H.C. Wainwright
-
-
-
-
-
-
-
Denali Therapeutics Inc. (DNLI) PT Raised to $45 at Jefferies
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

